219 related articles for article (PubMed ID: 28067715)
1. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration.
Côté N; Pibarot P; Clavel MA
Curr Opin Cardiol; 2017 Mar; 32(2):123-129. PubMed ID: 28067715
[TBL] [Abstract][Full Text] [Related]
2. Aortic Bioprosthetic Valve Durability: Incidence, Mechanisms, Predictors, and Management of Surgical and Transcatheter Valve Degeneration.
Rodriguez-Gabella T; Voisine P; Puri R; Pibarot P; Rodés-Cabau J
J Am Coll Cardiol; 2017 Aug; 70(8):1013-1028. PubMed ID: 28818190
[TBL] [Abstract][Full Text] [Related]
3. Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation.
Salaun E; Clavel MA; Rodés-Cabau J; Pibarot P
Heart; 2018 Aug; 104(16):1323-1332. PubMed ID: 29735584
[TBL] [Abstract][Full Text] [Related]
4. How to treat severe symptomatic structural valve deterioration of aortic surgical bioprosthesis: transcatheter valve-in-valve implantation or redo valve surgery?
Attias D; Nejjari M; Nappi F; Dreyfus J; Eleid MF; Rihal CS
Eur J Cardiothorac Surg; 2018 Dec; 54(6):977-985. PubMed ID: 29868728
[TBL] [Abstract][Full Text] [Related]
5. What is the best approach in a patient with a failed aortic bioprosthetic valve: transcatheter aortic valve replacement or redo aortic valve replacement?
Tourmousoglou C; Rao V; Lalos S; Dougenis D
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):837-43. PubMed ID: 25754372
[TBL] [Abstract][Full Text] [Related]
6. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.
Urso S; Calderón P; Sadaba R; Mahillo I; Tuñón J; Aldamiz G; Fraile J
J Card Surg; 2014 Jul; 29(4):439-44. PubMed ID: 24773571
[TBL] [Abstract][Full Text] [Related]
7. Selection of Valve Prostheses.
Rosu C; Soltesz EG
Semin Thorac Cardiovasc Surg; 2015; 27(2):152-8. PubMed ID: 26686441
[TBL] [Abstract][Full Text] [Related]
8. Structural deterioration of the Freestyle aortic valve: mode of presentation and mechanisms.
Mohammadi S; Baillot R; Voisine P; Mathieu P; Dagenais F
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):401-6. PubMed ID: 16872969
[TBL] [Abstract][Full Text] [Related]
9. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
[TBL] [Abstract][Full Text] [Related]
10. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
[TBL] [Abstract][Full Text] [Related]
11. Stented within a stentless aortic valve. A simple surgical solution for the replacement of a stentless aortic bioprosthesis.
Panagiotou M; Kogerakis N; Crockett JR; Economidou S
Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):7-8. PubMed ID: 19805504
[TBL] [Abstract][Full Text] [Related]
12. Failing surgical bioprosthesis in aortic and mitral position.
Mylotte D; Osnabrugge RL; Martucci G; Lange R; Kappetein AP; Piazza N
EuroIntervention; 2013 Sep; 9 Suppl():S77-83. PubMed ID: 24025964
[TBL] [Abstract][Full Text] [Related]
13. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
[TBL] [Abstract][Full Text] [Related]
14. Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.
Weber A; Noureddine H; Englberger L; Dick F; Gahl B; Aymard T; Czerny M; Tevaearai H; Stalder M; Carrel TP
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1075-83. PubMed ID: 22341653
[TBL] [Abstract][Full Text] [Related]
15. Mechanical versus bioprosthetic aortic valve replacement.
Head SJ; Çelik M; Kappetein AP
Eur Heart J; 2017 Jul; 38(28):2183-2191. PubMed ID: 28444168
[TBL] [Abstract][Full Text] [Related]
16. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old.
Kaneko T; Aranki S; Javed Q; McGurk S; Shekar P; Davidson M; Cohn L
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):117-26. PubMed ID: 24079878
[TBL] [Abstract][Full Text] [Related]
17. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations.
Bourguignon T; Bouquiaux-Stablo AL; Loardi C; Mirza A; Candolfi P; Marchand M; Aupart MR
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2004-2011.e1. PubMed ID: 24667021
[TBL] [Abstract][Full Text] [Related]
18. Undiagnosed mitroflow bioprosthesis deformation causing early structural valve deterioration.
Gennari M; Polvani G; Rubino M; Arlati F; Annoni A; Agrifoglio M
Gen Thorac Cardiovasc Surg; 2018 Sep; 66(9):543-545. PubMed ID: 29188430
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter aortic valve replacement in failed surgical valves.
Simonato M; Dvir D
Heart; 2019 Mar; 105(Suppl 2):s38-s43. PubMed ID: 30846524
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter Aortic and Mitral Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves: An 8-Year Single-Center Experience.
Ye J; Cheung A; Yamashita M; Wood D; Peng D; Gao M; Thompson CR; Munt B; Moss RR; Blanke P; Leipsic J; Dvir D; Webb JG
JACC Cardiovasc Interv; 2015 Nov; 8(13):1735-44. PubMed ID: 26476608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
